Lavigne Anne-Claire, Castells Magali, Mermet Jérôme, Kocanova Silvia, Dalvai Mathieu, Bystricky Kerstin
Université de Toulouse; Laboratoire de Biologie Moléculaire Eucaryote (LBME); F-31062 Toulouse, France; CNRS; LBME; F-31062 Toulouse, France.
PLoS One. 2014 Jun 9;9(6):e98930. doi: 10.1371/journal.pone.0098930. eCollection 2014.
Epithelial-Mesenchymal Transition (EMT) features appear to be key events in development and progression of breast cancer. Epigenetic modifications contribute to the establishment and maintenance of cancer subclasses, as well as to the EMT process. Whether histone variants contribute to these transformations is not known. We investigated the relative expression levels of histone macroH2A1 splice variants and correlated it with breast cancer status/prognosis/types.
To detect differential expression of macroH2A1 variant mRNAs in breast cancer cells and tumor samples, we used the following databases: GEO, EMBL-EBI and publisher databases (may-august 2012). We extracted macroH2A1.1/macroH2A1 mRNA ratios and performed correlation studies on intrinsic molecular subclasses of breast cancer and on molecular characteristics of EMT. Associations between molecular and survival data were determined.
We found increased macroH2A1.1/macroH2A1 mRNA ratios to be associated with the claudin-low intrinsic subtype in breast cancer cell lines. At the molecular level this association translates into a positive correlation between macroH2A1 ratios and molecular characteristics of the EMT process. Moreover, untreated Triple Negative Breast Cancers presenting a high macroH2A1.1 mRNA ratio exhibit a poor outcome.
These results provide first evidence that macroH2A1.1 could be exploited as an actor in the maintenance of a transient cellular state in EMT progress towards metastatic development of breast tumors.
上皮-间质转化(EMT)特征似乎是乳腺癌发生和发展的关键事件。表观遗传修饰有助于癌症亚类的建立和维持,以及EMT过程。组蛋白变体是否促成这些转变尚不清楚。我们研究了组蛋白macroH2A1剪接变体的相对表达水平,并将其与乳腺癌状态/预后/类型相关联。
为了检测乳腺癌细胞和肿瘤样本中macroH2A1变体mRNA的差异表达,我们使用了以下数据库:GEO、EMBL-EBI和出版商数据库(2012年5月至8月)。我们提取了macroH2A1.1/macroH2A1 mRNA比率,并对乳腺癌的内在分子亚类以及EMT的分子特征进行了相关性研究。确定了分子数据与生存数据之间的关联。
我们发现乳腺癌细胞系中macroH2A1.1/macroH2A1 mRNA比率升高与claudin-low内在亚型相关。在分子水平上,这种关联转化为macroH2A1比率与EMT过程的分子特征之间的正相关。此外,macroH2A1.1 mRNA比率高的未经治疗的三阴性乳腺癌患者预后较差。
这些结果提供了首个证据,表明macroH2A1.1可能作为一种因素参与维持EMT过程中向乳腺肿瘤转移发展的短暂细胞状态。